| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 2.22e-09 | 44 | 26 | 5 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 3.89e-09 | 49 | 26 | 5 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.42e-08 | 63 | 26 | 5 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 5.24e-07 | 129 | 26 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.43e-06 | 158 | 26 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | male gonad development | 2.11e-06 | 171 | 26 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 2.17e-06 | 172 | 26 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 4.43e-06 | 199 | 26 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 5.37e-06 | 207 | 26 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.59e-05 | 259 | 26 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | gonad development | 2.83e-05 | 292 | 26 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 3.07e-05 | 297 | 26 | 5 | GO:0045137 | |
| GeneOntologyBiologicalProcess | sex differentiation | 6.89e-05 | 352 | 26 | 5 | GO:0007548 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 7.46e-05 | 358 | 26 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 7.46e-05 | 358 | 26 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 7.87e-05 | 362 | 26 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 1.02e-04 | 197 | 26 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 1.03e-04 | 383 | 26 | 5 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 1.09e-04 | 388 | 26 | 5 | GO:0061458 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.02e-04 | 443 | 26 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | RNA splicing | 3.61e-04 | 502 | 26 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.52e-04 | 551 | 26 | 5 | GO:0006397 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 8.36e-04 | 34 | 26 | 2 | GO:0097107 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 1.40e-03 | 44 | 26 | 2 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.53e-03 | 46 | 26 | 2 | GO:1904861 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 4.36e-06 | 86 | 27 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | spliceosomal complex | 7.38e-06 | 215 | 27 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.29e-05 | 113 | 27 | 4 | GO:0043073 | |
| Domain | RBM1CTR | 1.74e-10 | 8 | 25 | 4 | PF08081 | |
| Domain | RBM1CTR | 1.74e-10 | 8 | 25 | 4 | IPR012604 | |
| Domain | RRM_1 | 1.57e-04 | 208 | 25 | 4 | PF00076 | |
| Domain | RRM | 1.85e-04 | 217 | 25 | 4 | SM00360 | |
| Domain | RRM_dom | 2.20e-04 | 227 | 25 | 4 | IPR000504 | |
| Domain | RRM | 2.31e-04 | 230 | 25 | 4 | PS50102 | |
| Domain | Nucleotide-bd_a/b_plait | 3.58e-04 | 258 | 25 | 4 | IPR012677 | |
| Domain | - | 4.10e-03 | 244 | 25 | 3 | 3.30.70.330 | |
| Domain | RING | 7.60e-03 | 305 | 25 | 3 | SM00184 | |
| Domain | Znf_RING | 9.12e-03 | 326 | 25 | 3 | IPR001841 | |
| Pubmed | 4.00e-15 | 7 | 27 | 5 | 8269511 | ||
| Pubmed | 1.50e-13 | 12 | 27 | 5 | 9598316 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 20016065 | ||
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 1.44e-12 | 5 | 27 | 4 | 8817321 | |
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 1.44e-12 | 5 | 27 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 1.44e-12 | 5 | 27 | 4 | 19737860 | |
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 4.31e-12 | 6 | 27 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 4.31e-12 | 6 | 27 | 4 | 12356914 | |
| Pubmed | 4.31e-12 | 6 | 27 | 4 | 18239052 | ||
| Pubmed | 4.31e-12 | 6 | 27 | 4 | 9499427 | ||
| Pubmed | 4.31e-12 | 6 | 27 | 4 | 15184870 | ||
| Pubmed | 4.31e-12 | 6 | 27 | 4 | 15051956 | ||
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.01e-11 | 7 | 27 | 4 | 10377282 | |
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.01e-11 | 7 | 27 | 4 | 8875892 | |
| Pubmed | 2.01e-11 | 8 | 27 | 4 | 7479793 | ||
| Pubmed | 6.03e-11 | 10 | 27 | 4 | 10601091 | ||
| Pubmed | 6.03e-11 | 10 | 27 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 1.42e-10 | 12 | 27 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 2.05e-10 | 13 | 27 | 4 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 2.87e-10 | 14 | 27 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 3.91e-10 | 15 | 27 | 4 | 14762062 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 6.81e-10 | 17 | 27 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 8.75e-10 | 18 | 27 | 4 | 12023983 | |
| Pubmed | 4.25e-09 | 26 | 27 | 4 | 35920200 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 9.56e-08 | 55 | 27 | 4 | 19468303 | |
| Pubmed | 1.19e-07 | 13 | 27 | 3 | 10749975 | ||
| Pubmed | 1.27e-07 | 59 | 27 | 4 | 11279525 | ||
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 5.80e-07 | 2 | 27 | 2 | 32473614 | |
| Pubmed | 8.74e-07 | 95 | 27 | 4 | 24029230 | ||
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 10332027 | ||
| Pubmed | The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. | 3.48e-05 | 241 | 27 | 4 | 12815422 | |
| Pubmed | 1.43e-04 | 347 | 27 | 4 | 16033648 | ||
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 2.17e-04 | 28 | 27 | 2 | 20309963 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 3.13e-04 | 171 | 27 | 3 | 20201926 | |
| Pubmed | 4.67e-04 | 41 | 27 | 2 | 23064961 | ||
| Pubmed | 6.14e-04 | 510 | 27 | 4 | 16712791 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.52e-04 | 231 | 27 | 3 | 16452087 | |
| Cytoband | Yq11.223 | 2.67e-07 | 93 | 27 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 3.21e-05 | 311 | 27 | 4 | chrYq11 | |
| Cytoband | 14q23.1 | 3.54e-04 | 47 | 27 | 2 | 14q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 2.67e-03 | 130 | 27 | 2 | chr14q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 2.54e-02 | 422 | 27 | 2 | chr20q13 | |
| GeneFamily | RNA binding motif containing | 3.78e-06 | 213 | 21 | 5 | 725 | |
| GeneFamily | Actins|Deafness associated genes | 7.52e-03 | 113 | 21 | 2 | 1152 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.85e-02 | 181 | 21 | 2 | 694 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 3.05e-08 | 33 | 26 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 1.10e-07 | 45 | 26 | 4 | MM763 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 5.22e-05 | 136 | 24 | 3 | e272d11bb52f890f6681cc9384aeac27976ec650 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.33e-05 | 137 | 24 | 3 | 12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 5.69e-05 | 140 | 24 | 3 | cade44740dd3acca7789591aa5a7935d48d5cbee | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 175 | 24 | 3 | 4d42a97c450e919a409477a7db85e2668f0d473b | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 177 | 24 | 3 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 178 | 24 | 3 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 178 | 24 | 3 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 178 | 24 | 3 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 178 | 24 | 3 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 179 | 24 | 3 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 179 | 24 | 3 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 179 | 24 | 3 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-04 | 179 | 24 | 3 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 181 | 24 | 3 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 181 | 24 | 3 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | 502361b041a036de024eb5fe378ca09fac9b67ee | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 24 | 3 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 189 | 24 | 3 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.47e-04 | 193 | 24 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 193 | 24 | 3 | 64a37dae3d631713b06d94691f5dcdb200dfef5e | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.49e-04 | 194 | 24 | 3 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 195 | 24 | 3 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | mLN-T_cell-Th17|mLN / Region, Cell class and subclass | 1.59e-04 | 198 | 24 | 3 | 04905f62941b193864704a10ad692faf777fa51d | |
| ToppCell | mLN-(1)_T_cell-(13)_Th17|mLN / shred on region, Cell_type, and subtype | 1.59e-04 | 198 | 24 | 3 | c575e9aeee4e034e8c4d171fe754403652343731 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 1.59e-04 | 198 | 24 | 3 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | e90155498397524b812c46f2412320230b445bb6 | |
| Drug | hydantoin-5-propionic acid | 7.89e-09 | 21 | 26 | 4 | CID000000782 | |
| Drug | AZFd | 1.17e-08 | 23 | 26 | 4 | CID000196489 | |
| Drug | Vistar | 7.67e-08 | 36 | 26 | 4 | CID000040896 | |
| Drug | bipy | 7.75e-08 | 97 | 26 | 5 | CID000001474 | |
| Drug | 2-chlorodideoxyadenosine | 1.60e-07 | 43 | 26 | 4 | CID000072194 | |
| Drug | PKI166 | 2.51e-07 | 48 | 26 | 4 | CID006918403 | |
| Drug | HgCl | 2.73e-07 | 49 | 26 | 4 | CID000024182 | |
| Drug | azafagomine | 5.06e-07 | 57 | 26 | 4 | CID011957435 | |
| Drug | thioglycolate | 9.75e-07 | 67 | 26 | 4 | CID000001133 | |
| Drug | SU6668 | 1.16e-06 | 70 | 26 | 4 | CID000206042 | |
| Drug | p11-13 | 1.54e-06 | 75 | 26 | 4 | CID000015759 | |
| Drug | 2-oyl | 5.90e-06 | 105 | 26 | 4 | CID000657137 | |
| Drug | carbonyl sulfide | 8.77e-06 | 116 | 26 | 4 | CID000010039 | |
| Drug | ara-AC | 1.42e-05 | 279 | 26 | 5 | CID000001805 | |
| Drug | oligoadenylate | 2.89e-05 | 157 | 26 | 4 | CID000107918 | |
| Drug | annamycin | 6.85e-05 | 11 | 26 | 2 | CID000115212 | |
| Drug | TR z | 3.70e-04 | 25 | 26 | 2 | CID000444705 | |
| Drug | taxol | 3.79e-04 | 560 | 26 | 5 | CID000004666 | |
| Drug | 5-aza-2'-deoxycytidine | 6.86e-04 | 638 | 26 | 5 | CID000016886 | |
| Drug | N-methylnicotinamide | 6.88e-04 | 34 | 26 | 2 | CID000064950 | |
| Drug | glycylsarcosine | 7.29e-04 | 35 | 26 | 2 | CID000093131 | |
| Disease | epilepsy (is_implicated_in) | 2.09e-05 | 9 | 23 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | acylcarnitine measurement | 1.29e-04 | 127 | 23 | 3 | EFO_0005059 | |
| Disease | cup-to-disc ratio measurement | 3.16e-04 | 430 | 23 | 4 | EFO_0006939 | |
| Disease | Neuroblastoma | 6.15e-04 | 47 | 23 | 2 | C0027819 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 7.24e-04 | 51 | 23 | 2 | EFO_0004869, EFO_0004872 | |
| Disease | Malignant neoplasm of breast | 1.23e-03 | 1074 | 23 | 5 | C0006142 | |
| Disease | colorectal cancer, hormone replacement therapy | 2.14e-03 | 88 | 23 | 2 | EFO_0003961, MONDO_0005575 | |
| Disease | hearing impairment | 2.64e-03 | 98 | 23 | 2 | C1384666 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNSHGGKKGNEEKMK | 326 | Q8IUX8 | |
| NEGKEDKGQHGMILG | 396 | Q9NZW4 | |
| DKGQHGMILGKGNVK | 401 | Q9NZW4 | |
| MENSGKANKKDTHDG | 1 | Q8IWF9 | |
| AKNAAKDMNGKSLHG | 61 | P0DJD3 | |
| AKNAAKDMNGKSLHG | 61 | A6NDE4 | |
| AKNAAKDMNGKSLHG | 61 | P0DJD4 | |
| AKNAAKDMNGKSLHG | 61 | P0C7P1 | |
| AKNAAKDMNGKSLHG | 61 | A6NEQ0 | |
| MDLEGDRNGGAKKKN | 1 | P08183 | |
| NKKLEGGQQVGMHSK | 931 | Q8TD19 | |
| MKDGNGNVALKDHGT | 886 | Q9Y6X6 | |
| GQLMKINVGHNNKGG | 231 | Q8IVV2 | |
| PGMKENVHNTENKGK | 776 | Q63HM2 | |
| LMAGNLNKKHEGGAK | 461 | Q16821 | |
| GKNKGKTEEPMLNQH | 341 | Q7Z3G6 | |
| EDEKHSKKGMDNQGH | 851 | P46100 | |
| SKKGMDNQGHKNLKT | 856 | P46100 | |
| EKNGENMGKKDKVQD | 466 | Q14721 | |
| VKLDGGKAHGGNNNK | 261 | Q7Z5L3 | |
| LQGHEKEMKGQVNKF | 301 | P49454 | |
| KELDKGVQGLNHGMD | 81 | Q6UWP8 | |
| GDGVEEEQGAKKHNM | 501 | O00167 | |
| KNMDHHRSKQKNGGD | 611 | Q6ZRF8 | |
| SFQGAKEMGGHNEKK | 606 | Q70JA7 | |
| AMLNAQKAGHGKSKG | 581 | Q96N96 | |
| DKPKMEKHNAQGQGN | 6 | P35813 | |
| HGGQLKKNMDENDKG | 146 | Q8TBZ6 | |
| KVKGDGQQHHMKDQE | 381 | Q496Y0 |